U.S. Allstate, Bluebird Bio, Vicinity Motor
Aug 15 (Reuters) -Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Allstate, Bluebird Bio and Vicinity Motor, on Thursday.
HIGHLIGHTS
* Allstate Corp ALL.N: CFRA cuts to hold from buy |
* Autodesk Inc ADSK.O: Baird raises target price to $295 from $289 |
* Bluebird Bio Inc BLUE.O: JP Morgan cuts to neutral from overweight |
* Provident Financial Services Inc PFS.N: KBW raises to outperform from market perform |
* Vicinity Motor Corp VEV.O: Alliance Global Partners cuts to hold from buy |
Following is a summary of research actions on U.S. companies reported by Reuters on Thursday. Stock entries are in alphabetical order.
* Accuray Inc ARAY.O: Jefferies raises target price to $5.5 from $5 |
* Akoya Biosciences Inc AKYA.O: Stephens cuts target price to $4 from $4.5 |
* Allstate Corp ALL.N: CFRA cuts to hold from buy |
* Alpha Teknova Inc TKNO.O: Stephens raises target price to $5 from $4 |
* American Tower Corp AMT.N: RBC raises target price to $236 from $225 |
* Anaptysbio Inc ANAB.O: Truist Securities raises target price to $30 from $20 |
* APA Corporation APA.O: Piper Sandler cuts target price to $29 from $34 |
* Autodesk Inc ADSK.O: Baird raises target price to $295 from $289 |
* Bakkt Holdings Inc BKKT.N: Jefferies raises target price to $13 from $11 |
* Bank Ozk OZK.O: Raymond James cuts target price to $50 from $54 |
* Berry Corporation (Bry) BRY.O: Piper Sandler cuts target price to $7 from $8 |
* Black Stone Minerals LP BSM.N: Piper Sandler cuts target price to $15 from $17 |
* Bluebird Bio Inc BLUE.O: Baird cuts target price to $6 from $7 |
* Bluebird Bio Inc BLUE.O: JP Morgan cuts to neutral from overweight |
* Brinker International Inc EAT.N: KeyBanc raises to overweight from sector weight |
* Brinker International Inc EAT.N: Piper Sandler raises target price to $62 from $56 |
* Cardinal Health Inc CAH.N: Baird raises target price to $137 from $130 |
* Cardinal Health Inc CAH.N: Evercore ISI raises target price to $115 from $105 |
* Cardinal Health Inc CAH.N: Leerink Partners raises target price to $127 from $122 |
* Cardinal Health Inc CAH.N: Mizuho raises target price to $110 from $104 |
* Cardinal Health Inc CAH.N: TD Cowen raises target price to $116 from $109 |
* Celcuity Inc CELC.O: Jefferies raises target price to $28 from $27 |
* Chord Energy Corp CHRD.O: Piper Sandler cuts target price to $206 from $234 |
* Cisco CSCO.O: Jefferies cuts target price to $53 from $56 |
* Civitas Resources Inc CIVI.N: Piper Sandler cuts target price to $85 from $103 |
* Comstock Resources Inc CRK.N: Piper Sandler cuts target price to $5 from $8 |
* Coterra Energy Inc CTRA.N: Piper Sandler cuts target price to $31 from $39 |
* Creative Realities Inc CREX.O: Alliance Global Partners raises target price to $7 from $6.5 |
* Dare Bioscience Inc DARE.O: Maxim Group cuts to hold from buy |
* Devon Energy Corp DVN.N: Piper Sandler cuts target price to $57 from $65 |
* Diamondback Energy Inc FANG.O: Piper Sandler cuts target price to $240 from $249 |
* Eli Lilly & Co LLY.N: HSBC raises target price to $1150 from $1100 |
* EOG Resources Inc EOG.N: Piper Sandler cuts target price to $147 from $154 |
* EQT Corp EQT.N: Piper Sandler cuts target price to $32 from $43 |
* European Wax Center Inc EWCZ.O: Jefferies cuts target price to $18 from $23 |
* Gilead GILD.O: Truist Securities raises target price to $83 from $82 |
* IGM Biosciences Inc IGMS.O: JP Morgan raises target price to $12 from $11 |
* IGM Biosciences Inc IGMS.O: Wedbush raises target price to $25 from $20 |
* Incyte INCY.O: RBC raises target price to $67 from $66 |
* Jones Lang LaSalle Inc JLL.N: Jefferies raises target price to $288 from $258 |
* Kellanova K.N: Barclays raises target price to $83 from $67 |
* Kellanova K.N: Piper Sandler raises target price to $83.5 from $63 |
* Kellanova K.N: RBC cuts to sector perform from outperform |
* Kellanova K.N: RBC raises target price to $83.5 from $76 |
* Kinetik Holdings Inc KNTK.N: RBC raises target price to $46 from $43 |
* Kodiak Gas Services Inc KGS.N: Truist Securities raises target price to $35 from $32 |
* Kodiak Sciences Inc KOD.O: Jefferies cuts target price to $3 from $4 |
* Lithium Americas (Argentina) Corp LAAC.N: National Bank of Canada cuts PT to $4.75 from $6 |
* Lithium Americas (Argentina) Corp LAAC.N: Scotiabank cuts target price to $4.25 from $8 |
* Lithium Americas Corp LAC.N: Scotiabank cuts target price to $3 from $5.5 |
* Lulu'S Fashion Lounge Holdings Inc LVLU.O: Jefferies cuts target price to $1.47 from $1.75 |
* Lumentum Holdings Inc LITE.O: Jefferies raises target price to $65 from $53 |
* Magnolia Oil & Gas Corp MGY.N: Piper Sandler cuts target price to $26 from $29 |
* Marathon Digital Holdings Inc MARA.O: Jefferies cuts target price to $17 from $22 |
* Marathon Oil Corp MRO.N: Piper Sandler raises target price to $37 from $34 |
* Mercury Systems Inc MRCY.O: Raymond James raises target price to $40 from $33 |
* Moderna MRNA.O: JP Morgan cuts target price to $88 from $96 |
* Paramount Global PARA.O: JP Morgan cuts target price to $11 from $12 |
* Paycor Hcm Inc PYCR.O: BTIG cuts target price to $20 from $26 |
* Paycor Hcm Inc PYCR.O: Jefferies raises target price to $13 from $11 |
* Paycor Hcm Inc PYCR.O: JP Morgan cuts target price to $17 from $19 |
* Paycor Hcm Inc PYCR.O: Raymond James raises target price to $17 from $16 |
* Performance Food Group Co PFGC.N: Jefferies raises target price to $90 from $84 |
* Portman Ridge Finance Corp PTMN.O: KBW cuts target price to $19 from $20 |
* Progressive Corp PGR.N: KBW raises target price to $255 from $245 |
* Progressive Corp PGR.N: Piper Sandler raises target price to $252 from $250 |
* Provident Financial Services Inc PFS.N: KBW raises target price to $21 from $20 |
* Provident Financial Services Inc PFS.N: KBW raises to outperform from market perform |
* Sachem Capital Corp SACH.A: Alliance Global Partners cuts target price to $3 from $3.5 |
* Sealed Air Corp SEE.N: JP Morgan cuts target price to $33 from $35 |
* Tencent Music Entertainment Group TME.N: JP Morgan cuts target price to $16 from $18 |
* Tyra Biosciences Inc TYRA.O: Piper Sandler initiates coverage with overweight rating |
* Tyra Biosciences Inc TYRA.O: Piper Sandler initiates coverage with target price $33 |
* Vaxart Inc VXRT.O: Oppenheimer initiates coverage with outperform rating |
* Vaxart Inc VXRT.O: Oppenheimer initiates coverage with target price $4 |
* Verrica Pharmaceuticals Inc VRCA.O: Needham cuts target price to $12 from $16 |
* Verrica Pharmaceuticals Inc VRCA.O: RBC cuts target price to $13 from $14 |
* Vicinity Motor Corp VEV.O: Alliance Global Partners cuts to hold from buy |
* Victoria'S Secret & Co VSCO.N: Barclays raises target price to $19 from $17 |
* Victoria'S Secret & Co VSCO.N: JP Morgan raises target price to $21 from $16 |
* Viracta Therapeutics Inc VIRX.O: RBC cuts target price to $4 from $6 |
* Western Digital Corp WDC.O: Evercore ISI removes stock from its tactical outperform list |
* Westlake Corp WLK.N: JP Morgan raises target price to $135 from $123 |
(Compiled by Bengaluru Newsroom)
</body></html>Relaterade tillgångar
Senaste nytt
Ansvarsfriskrivning: XM Group-enheter tillhandahåller sin tjänst enbart för exekvering och tillgången till vår onlinehandelsplattform, som innebär att en person kan se och/eller använda tillgängligt innehåll på eller via webbplatsen, påverkar eller utökar inte detta, vilket inte heller varit avsikten. Denna tillgång och användning omfattas alltid av i) villkor, ii) riskvarningar och iii) fullständig ansvarsfriskrivning. Detta innehåll tillhandahålls därför uteslutande som allmän information. Var framför allt medveten om att innehållet på vår onlinehandelsplattform varken utgör en uppmaning eller ett erbjudande om att ingå några transaktioner på de finansiella marknaderna. Handel på alla finansiella marknader involverar en betydande risk för ditt kapital.
Allt material som publiceras på denna sida är enbart avsett för utbildnings- eller informationssyften och innehåller inte – och ska inte heller anses innehålla – rådgivning och rekommendationer om finansiella frågor, investeringsskatt eller handel, dokumentation av våra handelskurser eller ett erbjudande om, eller en uppmaning till, en transaktion i finansiella instrument eller oönskade finansiella erbjudanden som är riktade till dig.
Tredjepartsinnehåll, liksom innehåll framtaget av XM såsom synpunkter, nyheter, forskningsrön, analyser, kurser, andra uppgifter eller länkar till tredjepartssajter som återfinns på denna webbplats, tillhandahålls i befintligt skick, som allmän marknadskommentar, och utgör ingen investeringsrådgivning. I den mån som något innehåll tolkas som investeringsforskning måste det noteras och accepteras att innehållet varken har varit avsett som oberoende investeringsforskning eller har utarbetats i enlighet med de rättsliga kraven för att främja ett sådant syfte, och därför är att betrakta som marknadskommunikation enligt tillämpliga lagar och föreskrifter. Se till så att du har läst och förstått vårt meddelande om icke-oberoende investeringsforskning och riskvarning om ovannämnda information, som finns här.
